Transdermal delivery of 5-fluorouracil (5-FU) by 1-alkylcarbonyl-5-FU prodrugs

被引:27
|
作者
Beall, HD [1 ]
Sloan, KB [1 ]
机构
[1] UNIV FLORIDA,DEPT MED CHEM,GAINESVILLE,FL 32610
关键词
1-alkylcarbonyl-5-FU; diffusion cell; water and lipid solubility; partition coefficients; flux; skin accumulation; solubility parameters;
D O I
10.1016/0378-5173(95)04327-6
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The members of a series of 1-alkylcarbonyl-5-FU prodrug derivatives have been characterized and evaluated for their abilities to deliver 5-FU into and through skin. There was no correlation of lipid solubility or partition coefficient with relative abilities of the members of the 1-alkylcarbonyl series to deliver 5-FU through skin. However, there was a correlation with water solubility within the series. Although their lipid solubilities and partition coefficient values were greater than those of the 1-alkyloxycarbonyl series, only 1-acetyl-5-FU was more soluble in water, and only 1-acetyl-5-FU delivered more total 5-FU species through the skin than the corresponding member of the 1-alkyloxycarbonyl series. On the other hand, the 1-alkylcarbonyl series was more effective at enhancing the ratio of dermal to transdermal delivery (D/T delivery ratio) than the 1-alkyloxycarbonyl series, presumably because of the rapid hydrolysis of the members of the former series once contact with the aqueous domains of the epidermis had been made. Thus, the hypothesis that enhanced D/T delivery ratio requires rapid hydrolysis of the prodrug after it partitions into the skin is supported. Although the prodrugs hydrolyzed rapidly in water, they were stable in isopropyl myristate (IPM) during their application in IPM to highly hydrated skin. There was also a good correlation of calculated solubility parameters for the prodrugs with their permeability coefficients.
引用
收藏
页码:203 / 210
页数:8
相关论文
共 50 条
  • [21] EXCRETION OF 5-FLUOROURACIL (5-FU) INTO PANCREATIC-JUICE
    TAKADA, T
    YASUDA, H
    UCHIYAMA, K
    HASEGAWA, H
    GASTROENTEROLOGY, 1993, 104 (04) : A454 - A454
  • [22] METABOLISM OF 5-FLUOROURACIL (5-FU) IN HUMAN GASTROINTESTINAL CANCER
    BERNE, M
    ALMERSJO, O
    GUSTAVSSON, B
    ACTA CHIRURGICA SCANDINAVICA, 1983, : 31 - 31
  • [23] TOLERANCE FOR 5-FLUOROURACIL (5-FU) IN RODENTS RECEIVING HYPERALIMENTATION
    SOUCHON, EA
    COPELAND, EM
    WATSON, P
    DUDRICK, SJ
    FEDERATION PROCEEDINGS, 1974, 33 (03) : 692 - 692
  • [24] 5-FLUOROURACIL(5-FU) IN PRIMARY TRABECULECTOMY - A RANDOMIZED TRIAL
    LOFTFIELD, K
    BALL, SF
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1991, 32 (04) : 745 - 745
  • [25] Modulation of plasma pharmacokinetics of 5-fluorouracil (5-FU) by eniluracil
    Abaogye, EO
    Saleem, A
    Osman, S
    Yap, J
    Harte, RJA
    Purnell, C
    O'Callaghan, M
    Lucas, VS
    Jones, T
    Price, PM
    BRITISH JOURNAL OF CANCER, 1999, 80 : 95 - 95
  • [26] TREATMENT OF EXPERIMENTAL ACUTE PANCREATITIS WITH 5-FLUOROURACIL (5-FU)
    JOHNSON, RM
    BARONE, RM
    NEWSON, BL
    DASGUPTA, TK
    NYHUS, LM
    AMERICAN JOURNAL OF SURGERY, 1973, 125 (02): : 211 - 222
  • [27] ALLERGIC CONTACT-DERMATITIS TO 5-FLUOROURACIL (5-FU)
    GOETTE, DK
    ODOM, RB
    CLINICAL RESEARCH, 1976, 24 (02): : A201 - A201
  • [28] Preoperative chemoradiotherapy with 5-fluorouracil (5-FU) or 5-FU/oxaliplatin (5FU/OX) for rectal cancer is a feasible treatment strategy in the elderly
    Dolinsky, C. M.
    Mahmoud, N. N.
    Mick, R.
    Sun, W.
    Whittington, R.
    Solin, L. J.
    Haller, D. G.
    O'Dwyer, P.
    Fry, R. D.
    Metz, J. M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : S308 - S308
  • [29] 5-fluorouracil (5-FU) plasma exposure and outcome in patients receiving a TPF (taxotere, cisplatin, 5-FU) chemotherapy
    Legand, C.
    Blasco, H.
    Benz, I.
    Chapet, C.
    Le Guellec, C.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2009, 23 : 25 - 25
  • [30] COMPARISON OF TREATMENT OF METASTATIC GASTROINTESTINAL CANCER WITH 5-FLUOROURACIL (5-FU) TO A COMBINATION OF 5-FU WITH CYTOSINE-ARABINOSIDE
    GAILANI, S
    HOLLAND, JF
    BURNINGHAM, R
    LEONE, L
    LARSEN, V
    FALKSON, G
    CANCER, 1972, 29 (05) : 1308 - +